Milta Medical Guide
Milta Medical Guide
Milta Medical Guide
-
--5-01
1
2
JSC UNITED SPACE DEVICE CORPORATION
Guidance on application
of magnet-IR-light-laser
therapeutic apparatus
MILTA-F-5-01
Moscow, 2005
3
Guidance on application of magnet-IR-light-laser therapeutic
apparatus MILTA-F-5-01, JSC United Space Device Corpora-
tion Moscow, 2005
Author: Chernyshev I. A.
Reviewer:
active member of the Academy for Military Sciences,
professor Illarionov V.E.,M.D.
4
LIST OF ABBREVIATIONS AND SPECIAL TERMS.
amper, SI unit of electric power.
BP blood pressure
APERTURE a slot in terminal of the device through which laser and
light diodes radiation is emitted.
V volt, a SI unit of electric tension, electromotive force, difference of
electric potentials
VA volt-amper, a unit of electric current total capacity
W watt, a SI unit of active capacity
Hz SI unit of frequency. 1 Hz frequency of periodical process at
which one cycle of the process occurs in one second.
J joule, a unit of work or a dose (1J=Ws)
IR infra-red (range of electro-magnetic radiation from 0.3 to 3mkm
used in therapy)
kg kilo
LT laser therapy
mW milli-watt (1mW=10-3W)
MIL magnet-IR-laser (therapy, action)
min minute
mKm unit of length (1mkm=10-6 km)
MLT magnet laser therapy
mm millimeter
mTl millitesla, a SI unit of magnetic induction
LLLR low-level-laser radiation
CMF constant magnetic field
s second
cm centimeter
CNS Central Nervous System
EMF electromotive force
5
FOREWORD
6
Apparatuses design allows it to use the following combinations of
actions: laser + light-emitting diodes; laser + magnet; light-emitting
diodes + magnet; laser-LEDs-magnet.
Clinical tests in leading scientific institutions in Russian and
abroad, as well as long clinical practice of MIL-therapy prove reliabili-
ty, safety and successive therapeutic effect of MILTA and MILTA-F-
type devices.
7
2. MECHANISM OF BIOLOGICAL AND THERAPEUTIC
ACTION BROUGHT BY CONSTANT MAGNETIC
FIELD. MAGNET-LASER THERAPY.
10
The device can be equipped with light-guide heads and a holding
support for the terminal.
Main technical parameters
magnetic induction in the center of terminals aperture , mTl . . . . . . . . . . . . . . . . . 20-80
pulse laser radiation:
wave length, mkm. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0,89
pulse duration, nc, at least . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 130
pulse power, W, at least . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5,(10)*
pulse repetition rate, Hz . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0; 5; 50;150; 600;1500
Continuous LEDs radiation
wave length, mkm . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0,85-0,95
average radiation power, mW . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0; 50;100
Exposure (irradiation period), min. . . . . . . . . . . . . . . . . . . from 1 to 9 , 1-minute interval
Light Indication:
power on;
irradiation period;
LEDs power level;
Laser radiation repetition rate;
Presence of laser and LEDs radiation.
Red illumination of irradiated area.
Sound indication of irradiation cease
Square of terminals aperture, cm2. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3,8
Fed from the mains with frequency 50Hz and power 220V though adapter.
Consumed energy, VA, no more than . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 15
dimensions, mm:
terminal . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 105x60x65
though adapter . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 120x60x40
Weight, kg:
terminal . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0,3
though adapter . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0,35
*) Option.
11
Design and principle of operation
The apparatus consists of a power supply unit with a plug ,
and a terminal with control panel, connected with an electrical
cable (Fig.1).
2
1
4 3
Fig. 1 The apparatus
12
3 6
2 8
7 5
9
Fig.B. The terminal (from below)
13
2
6
1
3
5
7 4
14
Terminal can be extended with light-guide probes through an
adapter sleeve with a thread. This adapter sleeve is fixed to the termi-
nal under the screw nut 2 (Fig. 2).
Before starting the apparatus check :
15
5. SAFETY MEASURES
People under 18 are not allowed with work with laser apparatus-
es. No special reequipment is required in the room where MILTA is
operated.
It is strictly prohibited to look into the terminal when the device
is on. It is prohibited to place any reflecting objects (rings, chromium-
plated objects, mirrors, etc.) opposite laser beam. When on, the device
mustnt be left unattended.
6. WORK ORDER
16
7. MAIN PRINCIPLES FOR MIL-THERAPY
17
Method of exposure
There is distinguished a contact method, when the terminal is in
the firm contact with irradiated area, and distant one (contact-free),
when there is a space between the terminal and irradiated area.
Treating terminal can be placed on the irradiated area motionless
(stable method), or moved (labial, or scanning method).
Methods of treatment are distributed in corresponding fields of
medicine.
Every disease described has a corresponding picture with a table,
where there are given areas (areas of organs projections) a terminal
should be placed on. Every area has its recommended frequency, dura-
tion and power of exposure.
18
19
7.1. Surgical disorders
20
1 2
Fig. 1
Exposed areas:
1., 2. Areas on the abdominal wall at the edges of the wound.
3. Projection of crural vessels.
21
Slow-healing and non-healing wounds, trophic ulcers.
22
2
1
3
Fig. 2
Exposed areas (in the case of diseased lower extremities).
1. Popliteal space (side of the diseased area)
2. Left infraclavicular region.
3. Projection of the vascular bundle (affected side).
4. Ulcers, wounds (if the damaged area is large, use scanning
method).
23
Erysipelatous inflammations.
24
2
3
Fig.3.
Exposed areas:
1. Area of the vascular bundle above the diseased area.
2. Area of the carotid arteries on the left and on the right.
3. Area of subclaviar arteries.
4. Inflammatory focus (a contact method in several zones, or distant-
ly with a scanning method)
25
Clean wounds and flesh post-operative scars.
MIL-therapy for clean wounds and fresh post-operative scars (as a
measure to prevent purulence) is conducted daily, in the morning,
starting from the second day (after the trauma or operation) for the
first 3 days, then after a day 4-5 more procedures (depending on the
progression of the wound-healing process). The terminal is placed 3-5
mm above the wound, extending to its circumference (a wound with a
square of up to 10 cm2 should be irradiated for 2 min). With vast
wounds 2-6 zones should be exposed to during one procedure, 1
minute for each. The number of these conventional zones depends on
the wounds size, and irradiated by the terminal area so that the
wound is fully covered. In the first 3 days the frequency used is 50 Hz,
the following days 50 Hz. LEDs output 50mW. The course con-
sists of 7-8 sessions.
Healing has primary tension without rough scarring.
Burns.
Self-treatment with MILTA can be conducted over thermal
skins and mucous coat injuries of small size (from fire, hot objects,
boiling water) immediately after being burned. MIL-treatment is car-
ried out distantly over open injured surfaces, 5-6 mm between the
burn and the terminal. Frequency used 50 Hz, duration 1 min,
LEDs output 50mW.
The course consists of 7-8 daily procedures.
Contusion.
MIL-treatment is carried out immediately after the injury of
arms, legs, back, buttocks muscles by scanning or stable method. Fre-
quency of treatment 1500 Hz, output 50 mW, procedure duration
2-4 minutes. The course is made of 5 daily procedures (there are pos-
sible 2 sessions in a day, with an 8-hour interval).
26
Purulent disorders of soft tissues.
When purulent abscess is formed, after surgical intervention
MIL-therapy is conducted in combination with traditional treatment
over 2-4 areas (depending on the size of damaged area), around inflam-
mations focus, exposing each area for 2 minutes with LEDs output 50
mW. Every consecutive procedure is done at a bew frequency in the fol-
lowing order: 5,50,150,600,1500 Hz. The course consists of 5-7 daily
procedures.
Fig. 4.
Exposed areas:
1. 2-4 points around the wound.
2. The wound
27
28
Purulent wounds.
When treating wounds, the MIL-therapy course can be extend-
ed up to 13 procedures (with the duration not exceeding 10 min).
Before the procedure the wound should be cleared from the discharge
and medicines (purulent discharge absorbs up to 90% of laser radia-
tion). If necessary, MIL-therapy can be conducted through sterile
gauze bandage. It is important to provide proper sterilization of the ter-
minals surface (wiping with 96% solution of ethyl alcohol), and fix a
protective sterile film on it.
Two procedures are carried daily during the first three days (one
in the morning, the other in 10-12 hours); their duration is 7 min, fre-
quency 50 Hz, LEDs output 50 mW. On the following 7 days there
is one procedure a day (in the first part of the day). Frequncy 150 Hz,
LEDs output 50 mW, duration 7 min.
After MIL-session wounds are treated as accepted in surgery.
Inflammation signs (erythema, edema, pain) are eliminated as
early as after 2 procedures (without MIL-therapy 5-6 days), healthy
granulation tissue starts forming in post-operative wounds on the 4-5th
day. Disablement period is reduced by 1.5-2 times in comparison with
traditional treatment.
29
7.2. Diseases of the joints. Traumas.
30
5
4
3
1
2
Fig.5
Exposed areas:
1. Articulations of hand from the palm (a scanning method).
2. Articulations of hand from the front (a scanning method).
3. Wrist joint (palm view)
4. Wrist joint (front view)
5. Lateral sides of the joint.
31
Shoulder and elbow joints.
(according to V.I. Korepanov)
32
Front view Lateral view
1
2
Rear view
3
1
Fig. 6
Exposed areas:
1. Shoulder joint from above.
2. Middle of the forearm
3. Shoulder joint from the front.
4. Shoulder joint from the back side.
5. Bend of the elbow
6. Lateral sides of the elbow joint.
7. Olecranon from the back side.
33
Epicondilitis (tennis elbow).
34
2
3
1
Fig.7
Exposed areas:
1. Area of most intense pain syndrome
2. Nuchal bone area (projection of the seventh cervical vertebra),
2 points to the right and to the left of it.
3. Interior angle of scapula.
35
Knee and ankle joints, articulations of the foot.
36
2 1
5
4
Fig. 8.
Exposed areas:
1. Areas above and below the patella
2. Lateral areas of the knee joint
3. Front area of the ankle joint
4. Back area of the ankle joint
5. Lateral areas of the ankle joint
37
Pelvis joint.
(according to V.I. Korepanov)
38
3
2
4
Fig.9
Exposed areas:
1. Greater trochanter area.
2. Two areas 5 cm above, below and on each side of area 1.
3. Area of the upper outward quadrant of the clunis
4. Pouparts ligament area
39
Spinal column disorders.
Osteochondrosis
(according to V.I. Korepanov).
Under osteochondrosis, treatment is done over manually distin-
quished sore points.
40
1 1
Fig.10
Exposed areas:
1. 7-8 areas of exposure along the spinal column, 1.5 cm on the left
and on the right
41
Traumatic periostitis.
(injury of the periosterum).
42
3
2
Fig.11
Exposed areas when lower extremity is injured:
1. Injured area
2. Area of vascular bundle projection
3. Area of crural vessels projection
43
Inflammatory process in tendons (tendovaginitis) and mus-
cles (myositis).
44
2
Fig. 12
Exposed areas:
1. Area of the sore muscle (except for muscles and tendons near
heart)
2. An area along the spinal column, which corresponds level of injury
(scanning method)
45
Arthrosis of temporomandibular joint.
46
1
Fig. 13
Exposed areas:
1. Area of the injured joint.
2. Area under lower jar angle.
3. Area of the spinal process of III cervical vertebra.
4. Areas to the right and to the left of the nuchal bone.
47
Cancaneal spurs.
48
1
Fig. 14
Exposed areas:
1. Plantar surface of foot
2. The area of attachment between the Achilles tendon and the can-
caneum
3. External and onlyng surface of the cancaneum
49
Traumatic injuries of bones and tendons.
50
3 2
Fig. 15
Exposed areas:
1. Area of bone fracture projection
2. Area of vascular bundle to be irradiated in case of lower leg frac-
tures.
3. Area of vascular bundle to be irradiated when a thigh bone is frac-
tured.
51
7.3. Diseases of the veins in the lower extremities.
52
2 3
Fig. 16
Exposed areas:
1. Thrombus area (inflamed vessel part), terminals movement is
shown by the arrow
2. Area of the crural vessels
3. Area of the vascular bundle above the injured vessel.
53
Atherosclerosis endarteriitis.
Obliterating endarterritis.
54
2
1
4
Fig. 17
Exposed areas:
1. Areas on the front-inner surface of lower extremity
(along the vessels).
2. Area of crural artery projection
3. Area from both sides of the Achilles tendons.
4. Area on the gastrochemius muscle (in the middle)
5. Popliteal space area.
6. Gluteal fold area
55
Varicous dilation of lower extremities veins.
(according to V.I. Korepanov).
56
6
1 5
3 4
Fig. 18
Exposed areas:
1. Area of the crural artery.
2. Patellar area
3. Area on the front-inner surface of the ankle
4. Ankle joint area.
5. Popliteal space area
6. Gluteal fold area.
If there is a vein pathology in left extremity, its corresponding areas
are irradiated.
57
Raynauds disease.
(according to V.I. Korepanov).
58
2
Fig. 19
Exposed areas:
1. Bend of the arm area
2. Paravertebrally, at the level of 3rd-6th cervical vertebra and 1st-
3rd of dorsal vertebra, at the affected side (scanning method).
3. Back of the hand (scanning method).
59
7.4. Neurology.
60
5
Fig. 20
Exposed areas:
1. Upper outward quadrant of the clumis
2. Gluteal fold area.
3. The middle in the back surface of the thigh
4. Popliteal space area
5. Lumbosacral spine (to the right and to the left of the spinal
column), scanning method.
61
Facial nerve neuritis. (Fig. 21 A).
The terminal is being put on a painful zone, then slowly moved
along skin surface (slightly touching), along the injured nerve trunk
following lines 1, 2 or 3. The frequency applied is 50 Hz , during 1 min
for the whole line. Under mascular weakness, the frequency should be
5 Hz, during 1 min for the whole line. The course is made of 10 daily
procedures. LEDs output is 50 mW. There can be also irradiated and
area under lower jar angle, duration 1 min, frequency 150 Hz.
Trifacial neuralgia. (Fig. 21 B).
Before starting MIL-procedures, cases of disseminated
encephalomielitis and tumpurs of the brain should be excluded. Expo-
sure has the following parameters: ferquency 5 Hz, duration 1-2
minutes for an area, output 50 mW, total duration not exceeding
8-10 min for one side of the face (areas 1, 2, or 3 depending on the posi-
tion of the injured nerve). The course lasts 10-12 procedures, carried
once a day. If required, this course can be repeated but not earlier than
in 4 weeks.
62
1
Fig. 21 , B
Exposed areas:
Fig.21
1. When ophthalmic nerve is affected
2. When maxillary nerve is affected
3. When mandibular nerve is affected
63
Stroke consequences.
64
3
4
1 5
2
6
Fig. 22
Exposed areas:
1. Supraclavicular fossae
2. Infraclavicular fossae
3. Frontotemporal areas (scanning method)
4. Suboccipital fossae
5. Paravertebrally, from both sides of the 7th cervical vertebra.
6. Spinal bone of the 7th cervical vertebra.
65
7.5. Diseases of nose, ear and throat.
66
1
Fig. 23
Exposed areas:
1. Matoid bone (behind the ear)
2. Projection of the Sinuses of Highmore
3. Spinal process of the third cervical vertebra
4. Projection of the thymus gland.
67
Tonsillitis, laryngotracheitis, pharyngotracheitis.
68
5
3
2
4
Fig. 24
Exposed areas:
1. Submandifular areas (under the anglers of the lower jar)
2. Jugular fossa area.
3. Trachea at the level of thyroid cartilage.
4. Thymus gland projection.
5. Spinal process of the third cervical vertebra.
6. Areas from both sides of the cervical vertebra (most prominent
vertebra).
69
Rhinitis (catarral, purulent, vasomotor),
exacerbation of chronic atrophic rhinitis).
70
4
2 2
Fig. 25
Exposed areas:
1. Wings of nose.
2. Areas under the lower jaw
3. Thymus gland projection
4. Spinal process of the third cervical vertebra
5. Areas from both sides of the spinal process of cervical vertebra
(most prominent vertebra)
71
Adenoid vegetations (I-II stages).
72
2
5 4
Fig. 26
Exposed areas:
1. Sinus of Highmores projection
2. Spinal process of the third cervical vertebra
3. Submandibular areas
4. Thymus gland projection
5. Area of Mohrenheims fossa on the right
73
Acute catarral otitis.
Otopyosis.
If otopyosis is suspected, MIL-therapy should be preceded by
paracentesis to provide outflow of pus. MIL-therapy is combined with
traditional methods of treatment.
Treatment should be prescribed by a doctor.
74
1
Fig. 27
Exposed areas:
1. Area of external auditory canal
2. Mastoid bone (behind the ear) from the diseased side.
3. Submandibular area, at the diseased side
4. Area of the spinal process of the third cervical vertebra.
75
Chronic cochleoneuritis.
1. Frequency is changes
daily in the following
order: 5,50,150,600, 2 min 50 mW
1500,600,150,
2. 50,50,5 Hz
76
2
Fig. 28
Exposed areas:
1. Mastoid bone (behind the ear)
2. Area of the external auditory canal.
77
Menieres disease.
78
2
Fig. 29
Exposed areas:
1. Mastoid bone (behind the ear)
2. Area of the external auditory canal.
3. Area of suboccipital fossa
79
7.6. Cardio-cascular diseases.
80
8
3 4
2
1 6
5
Fig. 30
Exposed areas:
1. Apex beat projection.
2. Second intercostal space near the left edge of the breast bone.
3. Second intercostal space near the right edge of the breast bone.
4. Areas to the right and to the left of the spinal column, middle of the
blade-bone.
5. Middle third of the breast bone.
6. Area to the left of the spinal column, angle of scapula level.
7. Left carotid artery area.
8. Areas to the left and to the right of the spinal column, at the level
of the third cervical vertebra.
81
Hypertensive disease (I-II class)
Arterial hypertension.
Symptomatic arterial hypertension.
82
2
Fig. 31
Exposed areas:
1. Area of carotic area pulsing on the left.
2. Area of upper dorsal and lower cervical vertebra to the right and to
the left (1.5-2 cm from the spinal column).
3. Kidneys projection from both sides.
4. Gall bladder area.
83
Hypertensive disease (second treatment method).
84
1 1
3
2
Fig. 32
Exposed areas:
1. Area from I cervical to VI cervical vertebra, on the right and on the
left of the spinal column.
2. Area of the second intercostal space to the left of the breast bone.
3. Area of the second intercostal space to the right of the breast bone
85
Stable stenocardia (I-IV functional class), stenocardia at
rest (first attack, progressing stenocardia).
Extrasystoli arrhythmia.
86
2 4
1
3
Fig. 33
Exposed areas:
1. The forth intercostal space on the left on the midclavicular line.
2. The second intercostal space to the left of the breast bone.
3. Gall bladder projection.
4. Area to the left of the spinal column , angle of scapula level.
87
Rhythm disturbance.
Treatment should be preceded with a cardiologists examination.
88
5
2 4
3
Fig. 34
Exposed areas:
1. Apex beat area
2. Area of the second intercostal space to the right of the breast bone
3. Area of the second intercostal space to the left of the breast bone.
4. Paravertebrally, on the right and on the left
(III-IV dorsal vertebra level)
5. Area of the left carotid artery.
89
7.7. Pulmonology
90
1 2
3
Fig. 35
Exposed areas:
1. An area at the level of III-IV intercostal space from the front.
2. An area near the spinal column at the level of inferior angle of
scapula, on the right and on the left.
3. An area in the middle of scapula, on the left and on the right of the
spinal column.
91
Chronic obstructive bronchitis in the exacerbation stage.
92
2
Fig. 36
Exposed areas:
1. Area of main bronchi projection between scapulas.
2. Area of shoulder girdle, on the left and on the right.
3. Area of ulnar vascular bundle.
93
Bronchial asthma.
94
5
1 3
8
2 4
6 6
7 7
Fig. 37
Exposed areas:
1. Supraclavicular fossae (on the right and on the left).
2. I-II intercostal space along mid-clavicular line on the right.
3. Area of jugular fossa.
4. Thymus gland projection.
5. Level of the interior angle of scapulas near the spinal column.
6. Middle axillary line.
7. Area of the elbow fossae.
8. Projection of the atrabiliary capsules (at the level of bottom ribs)
95
Acute pneumonia.
Chronic pneumonia.
96
3
2 2
Fig. 38
Exposed areas:
1. Ulnar vascular bundle area.
2. Supraclavicular and subclavicular fossa areas on the left and on
the right, depending on inflammation positioning.
3. Area of the spinal column at the level of inferior angle of scapula,
from both sides.
4. Area of the spinal column at the level of middle of scapula, from
both sides.
5. Area of the spinal column at the level of angle of scapula, from
both sides.
6. Area under scapula, from both sides.
97
7.8. Diseases of the gastro-intestinary tract.
98
6
5
3
1
Fig. 39
Exposed areas:
1. Epigastium area.
2. Area of the left hypochondium.
3. Area of the right hypochondium.
4. Middle point between ensisternum and omphalus.
5. Paravertebral areas from the angle of scapula up to upper lumbar
part (scanning method).
6. Supraclavicular area on the left.
99
Chronic cholecistitis.
Diskinesy of bile duct.
MIL-therapy reduces inflammatory process in the liver and gall
bladder, brings their function to the norm, eliminates spasms in the sphin-
ters of extrahepatic bile dusts, leads to a decrease in surface tension and
viscosity of the bile. MIL-therapy produces stimulative effect over lever
regeneration. Local immunity, disturbed by a pathological process, is also
brought up.
Contraindications for MIL-therapy are such states as hydroc-
holecystis, non-functioning gall bladder, destructive cholecyctitis,
cholelithiasis.
It is possible to treat cholelithiasis using MIL-therapy, if a patient
has sand or small single stones. In case of several stones of an average size
treatment can cause problems and be harmful. A doctor should be cau-
tious about any methods of ball bladder stimulation : if the disease of the
gall bladder is combined with ischemic heart disease, one should be aware
of cholescyto-coronal syndrome.
Treatment should be preceded by ultra-sound investigation.
100
3
6
2
5
1
4
Fig. 40
Exposed areas:
1. Area of gall bladder projection (right hypochondrium).
2. Points of the right costal arch, 4 cm above and below area 1.
3. Posterior triangle of neck on the right.
4. Area of omphalus.
5. The middle between 1st and 4th areas.
6. Area from angle of scapula and middle of lumbar part (scanning
method).
101
Chronic colitis (non-specific).
MIL-therapy should be preceded by examination (proctosigmoi-
doscope, X-ray-contarct examination) to confirm the diagnosis
chronic non-specific colitis. There is a number of diseases such as
diverticulosis and polyposis of colon, tumours, megacolon
(Hirschsprungs disease) which should be taken into account by a spe-
cialist when prescribing MIL-therapy.
Method of treatment.
Exposed areas Frequency Duration LEDs' output
1.
2.
3. 1 min
5 Hz
4. for every area
50 mW
5.
6.
2 min
7. 1500 Hz
for every area
102
7
1 5
Fig. 41
Exposed areas:
1. Area of liver angle of colon.
2. Area of splenic angle of colon.
3. Right iliac region.
4. Left iliac region.
5. A point between the ensisternum and omphalus.
6. Omphalus projection.
7. Paravertebral areas on both sides from the angles of scapula to
sacral part (scanning method).
103
Chronic pancreatitis.
Insuline-independent diabetes.
104
5
3 4
1 2
Fig. 42
Exposed areas:
1. Area of the right hypochondium.
2. Area of the left hypochondium
(projection of pancreas head and tail).
3. Epigastrium area.
4. Scanning irradiation on the left side along the spinal column from
the middle of scapula up to lumbar part.
5. Left subclavicular area (exposed every other day.)
105
7.9. Proctology.
106
1
3
6
5
Fig. 43
Exposed areas:
1. Area of the right hypochondium.
2. Area of the left hypochondium.
3. Iliac region of the left.
4. Points around the anus.
5. Projection of the crural vascular bundle
6. Sacral part of the spinal column, from both sides
(scanning method).
107
Anal fissures.
108
1
1 2
Fig. 44
Exposed areas:
1. Area around the anus (4 points), 2-3 cm from it
(contact or distant irradiation).
2. Area of the anal groove.
109
7.10 Gynecology.
5
3
Fig. 45
Exposed areas:
1. Uterine appaendages projection area.
2. Utrus projection area.
3. Crural vessels projection area
(irradiated only at the 4th and 8th day of the therapy).
4. Are of lumbosacral part.
5. Sole area.
111
Hyperplasia of endometrium.
112
2
Fig. 46
Exposed areas:
1. Left subclavicular area.
2. Thymus gland projection area.
3. Plantar surface of foot.
4. Iliac regions on the left and right.
5. Area above the public region.
113
Climacteric syndrome.
The daily procedures are conducted in the first part of the day.
The course duration is 8-10 sessions. In a month there is a repeated
course according the same scheme. MIL-therapy helps to normalize
central regulation of endocrine system, notably increase psycho-emo-
tional status and improve patients life.
114
2
1
3
5
4
Fig. 47
Exposed areas:
1. Apex beat area.
2. Subclavicular vascular bundle on the left.
3. Liver area.
4. Pancreas area.
5. Paravertebral areas on the left and right at the waist level
(3r d and 4th lumbar vertebrae).
115
7.11. Urology.
116
1
Fig. 48
Exposed areas:
1. Pubis area.
2. The middle of perineum (between the scrotum and anus).
117
Uretritis.
118
1
Fig. 49
Exposed areas:
1. Area of the urethra, from the front.
2. Area of the urethra, at rear.
119
Cystitis.
(according to V.I. Korepanov)
120
2
Fig. 50
Exposed areas:
1. Area above the pubis.(area of urinary bladder projection).
2. Lumbar-sacral part of the spine (on the left and right).
3. Projection of the crural vessels.
121
Enuresis.
122
2
3
1
Fig. 51
Exposed areas:
1. Area above the pubis.
2. Area of the solar plexus.
3. Area of the sacral bone, on the left and right (scanning method).
123
Chronic pyelonephritis.
124
1
Fig. 52
Exposed areas:
1. Area of kidneys projection.
2. Area of lumbar-sacral part of the spine (scanning method).
3. Area of the solar plexus.
125
7.12. Endocrine systems disorders.
126
3
2
Fig. 53
Exposed areas:
1. Area of trophic ulcer.
2. Subclavicular area on the left.
3. Area of thymus gland projection.
4. Area of inguinal vascular bundle.
127
Thyroid insufficiency (hypothyroidism) after autoimmune
thyroiditis in past , or partial resection of thyroid gland.
The procedures are carried out every other day, in the first part of
the day. Course duration 10-12 procedures. If therapeutic effect is
evident, the course is repeated in 3 months. Endocrinologists consulta-
tion is required.
128
2
1
3 4
Fig. 54
Exposed areas:
1. Projection areas of both lobes of the thyroid gland.
2. Areas on the right and on the left of the VII cervical vertebra.
3. Area of the liver.
4. Area of the pancreas.
129
Diabetes of the II type (non-insulin-dependent).
3.
2 min
4.
The procedures are done every other day, with course duration-
10-12 procedures.
A slight sugar increase in blood is observed immediately after the
first procedure in nearly all the patients. In 3-4 sessions the sugar con-
tent in the blood and urine decreases. Sugar content in the blood under
diabetes of the II type (either a patient takes different anti-diabetes
pills, or not) decreases 1.5-2 times on average, and depends on a
patients compensativeness. An amplitude decrease in daily fluctuation
of sugar content in the blood brought by MIL-therapy can be regard-
ed as a promising sign. MIL-therapy course can be repeated in 3-4
months.
Attention! It is not recommended to irradiate the pancreas
through lumbar region due to possible stimulation over adrenal cortex
and contra-insular action of corticosteroids.
130
3
2 4
Fig. 55
Exposed areas:
1. Area of pancreas projection.
2. Area of liver projection.
3. Area of thymus gland projection.
4. Area of the left subclavicular vascular bundle.
131
7.13. Dentistry.
132
3
Fig. 56
Exposed areas:
1. Projection of pathology focus on the cheek.
2. Mandibular angle area on the same side.
3. Spinal process of the III cervical vertebra.
4. The terminal is held close to frontal teeth.
133
7.14. Dermatology.
The course is made of 10 daily sessions, one session in the first part
of the day. The course can be repeated in 4 weeks, if required. Up to 4
courses are allowed during a year. MIL-therapy should be combined
with traditional medicines application ointments, solutions, etc.
If there are cutaneous psoriasic or herpetic eruptions, these areas
should be irradiated at the frequency of 1500 Hz, during 1 min for each
10 sq.sm, power 100 mW.
134
4
2 3
1
1
5
Fig. 57
Exposed areas:
1. Cubital fossae areas.
2. Liver projection.
3. Pancreas gland projection.
4. Kidneys projection.
5. Area of the skin in damaged zone (use a scanning method).
6. Area of crural vessels projection.
135
7.15. Chronic anemia.
136
1
Fig. 58
Exposed areas:
1. Thymus gland projection.
2. Spleen projection on the left (between the front and middle axillary
lines).
3. Area of the inguinal vascular bundles.
137
7.16. Diseases frequent in childhood.
1 3
6 5
4
Fig. 59
Exposed areas:
1. Area of the right hypochondium.
2. Area of epigastrium.
3. Area of the left hypochondium.
4. Iliac region on the right.
5. Iliac region on the left.
6. Paravertebral areas from both sides of lower-pectoral up to lumbar
part. (scanning method)
139
Allergic dermatosis.
Being a frequent case in paediatrics, this pathology is rooted in
inborn responsiveness altered by the allergy. In 80% of the cases it is an
inherited form of an allergic disease.
140
2
3
1
5
5
Fig. 60
Exposed areas:
1. Area of the left subclavicular vascular bundle.
2. Paravertebral areas on both sides of the VII cervical vertebra.
3. Thymus gland projection area.
4. Adrenal gland projection area.
5. Liver and pancreas projection.
6. Area of the right crural-inguinal vascular bundle.
141
7.17. Sport practice.
142
1
2
3
Fig. 61
Exposed areas:
1. Area of the VII cervical vertebra projection.
2. Area of thymus gland projection.
3. Area of kidneys, at the level of lower ribs.
4. Lumbar section of the spine (IV-V vertebra).
5. Area on the front-anterior surface of the calf,
four diametric fingers below the patella.
143
Stress, tiredness prevention, general improvement.
144
2
1
3
4
Fig. 62
Exposed areas:
1. Area of the left subclavicular region.
2. Area of the VII cervical vertebra.
3. Area of the right hypochondium (liver).
4. Area of the kidneys.
5. Area of the V lumbar vertebra
6. Area on the front-anterior surface of the calf, four diametric fin-
gers below the patella.
Areas are irradiated in the sequence shown.
145
7.18. Cosmetology.
Skin booster.
Therapy should be preceded with specialists advice cosmetol-
ogist and laser therapist. Laser therapy should be conducted over a
clean skin.
Eyelids and neck can be exposed only by a specialist.
The areas shown in Fig. 63 should be irradiated as the arrows
show, and with a scanning technique.
146
1
4 2
Fig. 63
147
CONCLUSION.
148
ASSORTED LITERATURE:
149
14. Application of therapeutic-diagnostic magnet-IR-laser apparatus-
es of MILTA-type in medical practice. Doctors manual in two
volumes. Part 1 (MIL-therapy), Part 2 (MIL-reflex therapy).
Compiled by V.A. Builin, candidate of Medical Sciences, J.V. Alex-
eyeva, MD., G.A. Antonova, C.M.S, V.F. Balakov, C.T.S, A.N.
Sheina. M.D.
15. Application of magent-IR-laser therapeutic apparatus with in-
built photometer MILTA-F in medical practice: Methodical
guidance/compiled by V.A. Builin/M., 1998.
16. Lasers in clinical medicine. Doctors manual /edited by
Pletnev/M., 1996.
17. Laser and magnet-laser therapy/edited by Polonsky A.K./
Moscow, VNIIMI, 1985.
18. Skobelkin O.K. Low-level lasers in clinical practice. Moscow, 1997.
19. New directions in laser medicine/Readings of international confer-
ence in Moscow, 1996/ edited by Skobelkin O.K.
20. Tkhorzhevskaya T.V. Magnet-laser therapy in complex treatment
of chronic bronchitis, aggravation stage.: Thesis, Moscow. 1997.
150
TABLE OF CONTENTS.
LIST OF ABBREVIATIONS AND SPECIAL TERMS.. . . . . . . . . . . . . . . 5
FOREWORD. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6
1. MECHANISM OF BIOLOGICAL AND THERAPEUTIC
ACTION OF LASER AND LEDS INFRA-RED RADIATION. . 7
2. MECHANISM OF BIOLOGICAL AND THERAPEUTIC
ACTION BROUGHT BY CONSTANT MAGNETIC FIELD.
MAGNET-LASER THERAPY. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8
3. MAIN AREAS OF APPLICATION FOR MILTA-F TYPE
DEVICES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 9
Indications for MIL-therapy . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 9
4. TECHNICAL PARAMETERS OF THE APPARATUS
MILTA-F-5-01 FOR MAGNET-LIGHT-LASER THERAPY . 10
Main technical parameters . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 11
Design and principle of operation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 12
5. SAFETY MEASURES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 16
6. WORK ORDER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 16
7. MAIN PRINCIPLES FOR MIL-THERAPY . . . . . . . . . . . . . . . . . . . 17
Method of exposure . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 18
7.1. Surgical disorders . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 20
Peritonitis. (a localized form). . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 20
Slow-healing and non-healing wounds, trophic ulcers. . . . . . . . . . . . 22
Erysipelatous inflammations. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 24
Clean wounds and fresh post-operative scars. . . . . . . . . . . . . . . . . . . . 26
Burns. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 26
Contusion.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 26
Purulent disorders of soft tissues. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 27
Purulent wounds. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 29
7.2. Diseases of the joints. Traumas. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 30
Wrist joint and articulations of hand. . . . . . . . . . . . . . . . . . . . . . . . . . . 30
Shoulder and elbow joints. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 32
Epicondilitis (tennis elbow). . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 34
Knee and ankle joints, articulations of the foot. . . . . . . . . . . . . . . . . . 36
Pelvis joint. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 38
Spinal column disorders. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 40
151
Osteochondrosis. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 40
Traumatic periostitis. (injury of the periosterum).. . . . . . . . . . . . . . . 42
Inflammatory process in a tendon (tendovaginitis)
and muscles (myositis). . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 44
Arthrosis of temporomandibular joint. . . . . . . . . . . . . . . . . . . . . . . . . . 46
Cancaneal spurs. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 48
Traumatic injuries of bones and tendons. . . . . . . . . . . . . . . . . . . . . . . . 50
7.3. Diseases of the veins in the lower extremities.. . . . . . . . . . . . . . . . . . . 52
Postthrombophlebitic syndrome (acute state). . . . . . . . . . . . . . . . . . . 52
Atherosclerosis endarteriitis. Obliterating endarterritis. . . . . . . . . . 54
Varicous dilation of lower extremities veins. . . . . . . . . . . . . . . . . . . . . 56
Raynauds disease.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 58
7.4. Neurology. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 60
Radiculitis. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 60
Facial nerve neuritis. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 62
Trifacial neuralgia.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 62
Stroke consequences. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 64
7.5. Diseases of nose, ear and throat. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 66
Antritis (sinusitis). . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 66
Tonsillitis, laryngotracheitis, pharyngotracheitis.. . . . . . . . . . . . . . . . 68
Rhinitis (catarral, purulent, vasomotor),
exacerbation of chronic atrophic rhinitis). . . . . . . . . . . . . . . . . . . . . . 70
Adenoid vegetations (I-II stages). . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 72
Acute catarral otitis. Otopyosis. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 74
Menieres disease. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 78
7.6. Cardio-cascular diseases. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 80
Ischemic heart disease.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 80
Hypertensive disease (I-II class). . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 82
Arterial hypertension. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 82
Symptomatic arterial hypertension. . . . . . . . . . . . . . . . . . . . . . . . . . . . 82
Hypertensive disease (second treatment method). . . . . . . . . . . . . . . 84
Stable stenocardia (I-IV functional class), stenocardia at rest
(first attack, progressing stenocardia).
Extrasystoli arrhythmia. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 86
Rhythm disturbance. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 88
7.7. Pulmonology . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 90
152
Acute and chronic bronchitis. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 90
Chronic obstructive bronchitis in the exacerbation stage. . . . . . . . . 92
Bronchial asthma. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 94
Acute pneumonia.Chronic pneumonia. . . . . . . . . . . . . . . . . . . . . . . . . . 96
7.8. Diseases of the gastro-intestinary tract. . . . . . . . . . . . . . . . . . . . . . . . . 98
Gastric and duodenal ulcer.Gastritis, duodenitis. . . . . . . . . . . . . . . . 98
Chronic cholecistitis.Diskinesy of bile duct. . . . . . . . . . . . . . . . . . . . . 100
Chronic colitis (non-specific). . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 102
Chronic pancreatitis.Insuline-independent diabetes.. . . . . . . . . . . . . 104
7.9. Proctology. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 106
Hemorrhoid. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 106
Anal fissures.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 108
7.10 Gynecology.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 110
Salpingitis, oophoritis, chronic salpingo-oophoritis with pain
syndrome, commissural process in , infertility caused by
obstruction in tubes, algodismenorrhea, itch and
craurosis of the vulva.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 110
Hyperplasia of endometrium. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 112
Climacteric syndrome. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 114
7.11. Urology. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 116
Acute and chronic prostatitis. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 116
Uretritis. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 118
Cystitis. (according to V.I. Korepanov) . . . . . . . . . . . . . . . . . . . . . . . . 120
Enuresis. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 122
Chronic pyelonephritis. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 124
7.12. Endocrine systems disorders. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 126
Diseases of the veins in the lower extremities under diabetes
(diabetic angiopathy), trophic ulcers. . . . . . . . . . . . . . . . . . . . . . . . . . . 126
Thyroid insufficiency (hypothyroidism) after autoimmune
thyroiditis in past , or partial resection of thyroid gland. . . . . . . . . . 128
Diabetes of the II type (non-insulin-dependent).. . . . . . . . . . . . . . . . 130
7.13. Dentistry.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 132
Inflammatory processes in:-gums (paradontosis);
-periosteum (periostitis);
-mucous coat (stomatitis);
post-operative and traumatic injuries of the tissues in mouth.
Over-sensitiveness (hyperthensia) of enamel. . . . . . . . . . . . . . . . . . . . 132
153
7.14. Dermatology. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 134
Viral dermatosis (herpes).Eczema. Neurodermitis. Psoriasis. . . . . . 134
7.15. Chronic anemia.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 136
7.16. Diseases frequent in childhood. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 138
Gastroenterology. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 138
Allergic dermatosis. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 140
7.17. Sport practice. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 142
Swift rehabilitation for athletes after overloads and traumas.. . . . . 142
To activate a productive psychological state before competitions.. 142
Stress, tiredness prevention, general improvement. . . . . . . . . . . . . . . 144
7.18. Cosmetology. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 146
Skin booster. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 146
CONCLUSION. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 148
ASSORTED LITERATURE: . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 149
TABLE OF CONTENTS. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 151
154